Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
SARS-CoV-2 vaccines have shown very high effectiveness in real-world scenarios. However, there is compelling evidence for a fast-paced waning of immunity. The increasing number of new variants that could alter the severity, transmissibility, and potential to evade the immune response raised signific...
- Autores:
-
Lopera, Tulio J.
Chvatal-Medina, Mateo
Flórez-Álvarez, Lizdany
Zapata-Cardona, Maria I.
Taborda, Natalia A.
Rugeles, Maria T.
Hernández López, Juan Carlos
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2022
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/45974
- Acceso en línea:
- https://hdl.handle.net/20.500.12494/45974
- Palabra clave:
- SARS-CoV-2
vaccine
neutralizing antibodies
immunity
immunogenicity
variant
- Rights
- openAccess
- License
- Atribución